Transdermal 17-beta-estradiol and risk of developing type 2 diabetes in a population of healthy, nonobese postmenopausal women.
about
Metabolic disorders in menopauseMenopause, hormone therapy and diabetes.Menopausal hormone therapy and new-onset diabetes in the French Etude Epidemiologique de Femmes de la Mutuelle Générale de l'Education Nationale (E3N) cohort.Urinary isoflavonoids and risk of type 2 diabetes: a prospective investigation in US women.Effect of ovarian suppression with gonadotropin-releasing hormone agonist on glucose disposal and insulin secretion.Type and route of estrogen administration.Primary prevention of cardiovascular disease with HRT.Prevention of type 2 diabetes; a systematic review and meta-analysis of different intervention strategies.Diabetes and Menopause.The association between sleep duration, snoring and prevalent type 2 diabetes mellitus with regard to gender and menopausal status: the CKB study in Zhejiang rural area, China.Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial.Raloxifene modifies the insulin sensitivity and lipid profile of postmenopausal insulin resistant women.Reproductive history and risk of type 2 diabetes mellitus in postmenopausal women: findings from the Women's Health Initiative.Role of Estrogens in the Regulation of Liver Lipid Metabolism.
P2860
Q26795571-DFC84164-2A2B-42C6-A199-643758ACD1CCQ30239769-729DE680-1E3F-47E3-8AF9-B6146B8A15CAQ35618612-E56FA090-C6A7-44EA-8F50-2A86A6381530Q36604298-5203C79B-D4C1-413F-8226-56CBDD1041E9Q36732072-F4B9D226-BEDC-49D1-B6D5-AE45A6755E4EQ37610402-B5BCDD48-12F0-423E-8C1F-76A161DFF11AQ37968650-AD5D5ED3-0751-46D7-A981-D29AFEDEED16Q38183131-F5F32AAC-F564-4875-865C-99DB146F7186Q38734483-4D9E3C7D-AD34-47B5-A689-AD3E3C6E9452Q39353956-6A5D9F9B-AAF6-40A6-937C-4A9F44D1DF9EQ40496635-E41EA87B-8172-4227-83EE-A7A257EE23A6Q45895178-A44272B5-D45A-4A87-A8E3-ABC8D8C4B81AQ46180967-69BC5227-3538-496A-BF6A-E36F5C23AD7DQ47311531-FFCA1C19-2321-4C27-A5CA-613C6C66C8B0
P2860
Transdermal 17-beta-estradiol and risk of developing type 2 diabetes in a population of healthy, nonobese postmenopausal women.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Transdermal 17-beta-estradiol ...... nonobese postmenopausal women.
@en
Transdermal 17-beta-estradiol ...... nonobese postmenopausal women.
@nl
type
label
Transdermal 17-beta-estradiol ...... nonobese postmenopausal women.
@en
Transdermal 17-beta-estradiol ...... nonobese postmenopausal women.
@nl
prefLabel
Transdermal 17-beta-estradiol ...... nonobese postmenopausal women.
@en
Transdermal 17-beta-estradiol ...... nonobese postmenopausal women.
@nl
P356
P1433
P1476
Transdermal 17-beta-estradiol ...... nonobese postmenopausal women.
@en
P2093
Giorgia Origliani
P304
P356
10.2337/DIACARE.27.3.645
P407
P577
2004-03-01T00:00:00Z